Epic Sciences’s DefineMBC laboratory developed liquid biopsy test has been designed to aid clinicians in the identification and classification of metastatic breast cancer.
In May, Epic Sciences released additional data demonstrating its efficacy and on 1 June, the company announced that it...
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?